Publicacions en què col·labora amb Francisco José García Hernández (60)

2023

  1. Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival

    Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1695-1703

  2. The complex HLA-E-nonapeptide in Behçet disease

    Frontiers in Immunology, Vol. 14

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

  2. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

    Autoimmunity Reviews, Vol. 19, Núm. 5

2019

  1. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease

    Frontiers in Immunology, Vol. 10

  2. Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes

    Scientific Reports, Vol. 9, Núm. 1

  3. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  4. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients

    Rheumatology International, Vol. 39, Núm. 11, pp. 1875-1882

  5. Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry

    Clinical Rheumatology, Vol. 38, Núm. 4, pp. 1117-1124

2018

  1. Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study (Clinical Rheumatology, (2018), 37, 4, (999-1009), 10.1007/s10067-017-3936-7)

    Clinical Rheumatology

  2. First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study

    Clinical Rheumatology, Vol. 37, Núm. 4, pp. 999-1009

2017

  1. A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294

  2. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

    Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457

  3. Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review

    Clinical and Experimental Rheumatology, Vol. 35, pp. S89-S97

  4. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 35, pp. S98-S105

  5. Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344

  2. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies

    Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399